Woodline Partners’s Biohaven BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$114M Buy
7,660,280
+7,359,891
+2,450% +$79.2M 0.35% 55
2026
Q1
$2.54M Hold
300,389
0.01% 777
2025
Q4
$3.39M Hold
300,389
0.01% 699
2025
Q3
$4.51M Hold
300,389
0.02% 594
2025
Q2
$4.24M Sell
300,389
-300,060
-50% -$5.35M 0.02% 595
2025
Q1
$14.4M Sell
600,449
-1,473
-0.2% -$51.9K 0.09% 294
2024
Q4
$22.5M Sell
601,922
-321,885
-35% -$15M 0.15% 194
2024
Q3
$46.2M Buy
923,807
+116,720
+14% +$4.54M 0.39% 70
2024
Q2
$28M Buy
807,087
+598,609
+287% +$23.7M 0.27% 117
2024
Q1
$11.4M Sell
208,478
-534,637
-72% -$26.5M 0.1% 243
2023
Q4
$31.8M Buy
743,115
+207,042
+39% +$6.44M 0.35% 84
2023
Q3
$13.9M Buy
536,073
+244,492
+84% +$5.08M 0.16% 176
2023
Q2
$6.97M Buy
291,581
+89,285
+44% +$1.54M 0.08% 256
2023
Q1
$2.76M Hold
202,296
0.04% 379
2022
Q4
$2.81M Buy
+202,296
New +$2.86M 0.04% 425

Other funds holding BHVN

Woodline Partners's BHVN Position: Q2 2026 in Review

Woodline Partners increased its Biohaven (BHVN) stake by 2,450% in Q2 2026, buying an estimated $79.2M and bringing the position to 7,660,280 shares worth $114M. The position accounts for 0.35% of the portfolio, ranked #55.

Woodline Partners first reported a position in BHVN in Q4 2022 and has held it in 15 quarters since. 293 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

  • Woodline Partners held 7,660,280 shares of Biohaven worth $114M as of Q2 2026.
  • Woodline Partners bought 7,359,891 Biohaven shares in Q2 2026, an estimated $79.2M.
  • Biohaven made up 0.35% of Woodline Partners's portfolio in Q2 2026, its #55 holding.
  • Woodline Partners first reported a position in Biohaven in Q4 2022 and has held it in 15 quarters since.
  • 293 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on Woodline Partners's 13F filing for Q2 2026, filed 14 Aug 2026.